CONOLIDINE NO FURTHER A MYSTERY

These outcomes, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the notion of targeting ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Ailments.These outcomes advise that conolidine is ready to